{"id":"NCT01785849","sponsor":"Amgen","briefTitle":"Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03-12","primaryCompletion":"2014-05-22","completion":"2014-06-12","firstPosted":"2013-02-07","resultsPosted":"2017-03-27","lastUpdate":"2019-08-26"},"enrollment":508,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hyperparathyroidism, Secondary"],"interventions":[{"type":"DRUG","name":"Etelcalcetide","otherNames":["AMG 416","KAI-4169"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Etelcalcetide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is designed to assess the efficacy and safety of etelcalcetide compared with placebo in the treatment of SHPT in patients with chronic kidney disease (CKD) receiving hemodialysis.","primaryOutcome":{"measure":"Percentage of Participants With a > 30% Decrease From Baseline in Mean PTH During the Efficacy Assessment Phase","timeFrame":"Baseline and the efficacy assessment phase (EAP; defined as Weeks 20 to 27, inclusive).","effectByArm":[{"arm":"Placebo","deltaMin":8.3,"sd":null},{"arm":"Etelcalcetide","deltaMin":74,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":10},"locations":{"siteCount":118,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","France","Germany","Hungary","Israel","Italy","Poland","Russia","Spain","United Kingdom"]},"refs":{"pmids":["28097355","28274835","29392552","28803497","28508378","30875390","31317120","32082556","31199098"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":78,"n":254},"commonTop":["Blood calcium decreased","Muscle spasms","Nausea","Vomiting","Headache"]}}